These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7187166)

  • 1. [Clinical experiences and value of vasodilation in myocardial insufficiency].
    Just H
    Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():87-97. PubMed ID: 7187166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of vasodilators in treating cardiac insufficiency].
    Malamov E
    Vutr Boles; 1980; 19(5):10-5. PubMed ID: 7003916
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacology of vasodilator drugs; recent developments].
    van Zwieten PA; van Meel JC; de Jonge A; Kalkman HO; Timmermans PB
    Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():78-86. PubMed ID: 7187165
    [No Abstract]   [Full Text] [Related]  

  • 4. Concepts of peripheral circulatory control: implications for vasodilator therapy in heart failure.
    Rubin SA; Swan HJ
    Cardiovasc Clin; 1984; 14(3):19-29. PubMed ID: 6144389
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of vasodilator agents in cardiac insufficiency].
    Ino-Oka E; Maruyama Y; Isoyama S; Satoh S
    Nihon Rinsho; 1982; 40(11):2376-81. PubMed ID: 6759701
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasodilation therapy].
    Widimský J
    Vnitr Lek; 1983 Mar; 29(3):274-82. PubMed ID: 6858011
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of peripheral vasodilator agents in chronic cardiac insufficiency].
    Zhukova AA; Eliseev OM
    Vopr Revm; 1982; (1):48-55. PubMed ID: 7046243
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasodilator therapy in cardiac failure what was new is old.
    O'Rourke MF; Nichols WW
    J Am Coll Cardiol; 2009 Mar; 53(10):898; discussion 898-99. PubMed ID: 19264253
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vasodilator agents in treatment of cardiac insufficiency].
    De Servi S; Specchia G
    G Ital Cardiol; 1978; 8(7):803-4. PubMed ID: 98381
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathophysiological considerations in selecting vasodilator therapy for CHF.
    Cohn JN
    Acta Med Scand Suppl; 1981; 652():93-7. PubMed ID: 6949468
    [No Abstract]   [Full Text] [Related]  

  • 11. Vasodilator treatment for acute and chronic heart failure.
    Chatterjee K; Parmley WW
    Br Heart J; 1977 Jul; 39(7):706-20. PubMed ID: 884021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vasodilator therapy in cardiac insufficiency].
    Vincent JL; Goldstein J; Leeman M; Lignian H
    Rev Med Brux; 1984 Nov; 5(9):589-92. PubMed ID: 6522891
    [No Abstract]   [Full Text] [Related]  

  • 13. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
    Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L
    Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of cardiac insufficiency with systemic vasodilator agents].
    García Puig J; Gil Aguado A; Arnalich F; Gaspar G; Anciones B; Vázquez JJ
    Med Clin (Barc); 1980 Nov; 75(9):398-403. PubMed ID: 7464335
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myocardial oxygen consumption and relationship to cardiovascular effects of clinical inodilators].
    Honerjäger P; Mitrovic V; Schlepper M
    Med Klin (Munich); 1994 Feb; 89(2):89-94. PubMed ID: 8164602
    [No Abstract]   [Full Text] [Related]  

  • 16. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
    Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B
    G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vasodilation therapy in severe cardiac insufficiency. A review and therapeutic proposals without invasive hemodynamic monitoring].
    Sørensen JN; Godtfredsen J
    Ugeskr Laeger; 1981 Oct; 143(43):2792-6. PubMed ID: 7324227
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of ultrasonic and microsphere techniques to evaluate regional aspects of vasodilator therapy in myocardial ischaemia, arterial hypertension and heart failure.
    Giudicelli JF; Berdeaux A; Richer C; Thuillez C
    J Hypertens Suppl; 1992 Jul; 10(5):S29-36. PubMed ID: 1403230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warner heart oration--1979. Vasodilators in heart failure.
    Ghosh JC
    Indian Heart J; 1979; 31(4):191-202. PubMed ID: 489034
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasodilator agents in chronic heart failure.
    Chatterjee K
    Dan Med Bull; 1983 Apr; 30 Suppl 1():1-9. PubMed ID: 6345096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.